CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 26, Issue 18, 2008, Pages 3031-3037

  Jones, Terreia S ^a   Kaste, Sue C ^a   Liu, Wei ^a   Cheng, Cheng ^a   Yang, Wenjian ^a   Tantisira, Kelan G ^a   Pui, Ching Hon ^a   Relling, Mary V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GLUCOCORTICOID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRHR1 GENE; DNA POLYMORPHISM; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECT; GENETICS; HAPLOTYPE; LYMPHATIC LEUKEMIA; METABOLISM; SURVIVOR;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BONE DENSITY; FEMALE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SURVIVORS;

EID: 46449109175     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.6399     Document Type: Article

References (55)

1. Kaste SC, Jones-Wallace D, Rose SR, et al: Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 15:728-734, 2001
2. Kaste SC, Rai SN, Fleming K, et al: Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 46: 77-87, 2006
3. Brennan BM, Rahim A, Adams JA, et al: Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 79:1859-1863, 1999
4. Halton JM, Atkinson SA, Fraher L, et al: Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774-1783, 1996
5. Stanisavljevic S, Babcock AL: Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res 125:139-144, 1977
6. Ragab AH, Frech RS, Vietti TJ: Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580-585, 1970
7. Nesbit M, Krivit W, Heyn R, et al: Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer 37:1048-1057, 1976
8. Shane E, Rivas MC, Silverberg SJ, et al: Osteoporosis after cardiac transplantation. Am J Med 94:257-264, 1993
9. Joseph JC: Corticosteroid-induced osteoporosis. Am J Hosp Pharm 51:188-197, 1994
10. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352-364, 1990
11. Bockman RS, Weinerman SA: Steroidinduced osteoporosis. Orthop Clin North Am 21:97-107, 1990
12. Sala A, Barr RD: Osteopenia and cancer in children and adolescents: The fragility of success. Cancer 109:1420-1431, 2007
13. Nevinny HB, Krant MJ, Moore EW: Metabolic studies of the effects of methotrexate. Metabolism 14:135-140, 1965
14. Thomsen OO, Cortot A, Jewell D, et al: A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med 339:370-374, 1998
15. Tantisira KG, Lake S, Silverman ES, et al: Corticosteroid pharmacogenetics: Association of sequence variants in CRHR-1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 13:1353-1359, 2004
16. Hiraoka M, Tsukahara H, Matsubara K, et al: A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 41:1155-1162, 2003
17. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al: Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 130:487-495, 1999
18. Szefler SJ, Martin RJ, King TS, et al: Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109: 410-418, 2002
19. Tornatore KM, Reed K, Walshe JJ, et al: Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients. Pharmacotherapy 14:111-118, 1994
20. Pui CH, Mahmoud HH, Rivera GK, et al: Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 92: 411-415, 1998
21. Pui CH, Sandlund JT, Pei D, et al: Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104:2690-2696, 2004
22. Evans WE, Relling MV, Rodman JH, et al: Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 338:499-505, 1998
23. Nussdorfer GG, Mazzocchi G, Robba C, et al: Effects of ACTH and dexamethasone on the zona glomerulosa of the rat adrenal cortex: An ultrastructural stereologic study. Acta Endocrinol (Copenh) 85:608-614, 1977
24. Kalkwarf HJ, Zemel BS, Gilsanz V, et al: The Bone Mineral Density in Childhood Study (BMDCS): Bone Mineral Content and Density According to Age, Sex and Race. J Clin Endocrinol Metab 92: 2087-2099, 2007
25. Rosen CJ, Bouxsein ML: Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43, 2006
26. Gilsanz V, Gibbens DT, Roe TF, et al: Vertebral bone density in children: Effect of puberty. Radiology 166:847-850, 1988
27. Hijiya N, Panetta JC, Zhou Y, et al: Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 108:3997-4002, 2006
28. Breiman L, Friedman JH, Olshen RA, et al: Classification and Regression Trees. Belmont, CA, Wadsworth International Group, 1984, pp 27-43
29. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927, 1995
30. Sweeney C, Curtin K, Murtaugh MA, et al: Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 15:744-749, 2006
31. Khatib H, Heifetz E, Dekkers JC: Association of the protease inhibitor gene with production traits in Holstein dairy cattle. J Dairy Sci 88:1208-1213, 2005
32. Jones G, Dwyer T: Bone mass in prepubertal children: Gender differences and the role of physical activity and sunlight exposure. J Clin Endocrinol Metab 83:4274-4279, 1998
33. El-Hajj Fuleihan G, Nabulsi M, Tamim H, et al: Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. J Clin Endocrinol Metab 91:405-412, 2006
34. McVeigh JA, Norris SA, Cameron N, et al: Associations between physical activity and bone mass in black and white South African children at age 9 yr. J Appl Physiol 97:1006-1012, 2004
35. Bass S, Pearce G, Bradney M, et al: Exercise before puberty may confer residual benefits in bone density in adulthood: Studies in active prepubertal and retired female gymnasts. J Bone Miner Res 13:500-507, 1998
36. McCulloch RG, Bailey DA, Houston CS, et al: Effects of physical activity, dietary calcium intake and selected lifestyle factors on bone density in young females. CMAJ 142:221-227, 1990
37. Sentipal JM, Wardlaw GM, Mahan J, et al: Influence of calcium intake and growth indexes on vertebral bone mineral density in young females. Am J Clin Nutr 54:425-428, 1991
38. Aguilera G, Nikodemova M, Wynn PC, et al: Corticotropin releasing hormone receptors: Two decades later. Peptides 25:319-329, 2004
39. Dautzenberg FM, Hauger RL: The CRF peptide family and their receptors: Yet more partners discovered. Trends Pharmacol Sci 23:71-77, 2002
40. Garnett SP, Hogler W, Blades B, et al: Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 80:966-972, 2004
41. Warholm M, Guthenberg C, Mannervik B, et al: Purification of a new glutathione S-transferase (transferase μ) from human liver having high activity with benzo{α}pyrene-4,5-oxide. Biochem Biophys Res Commun 98:512-519, 1981
42. Nelson DA, Simpson PM, Johnson CC, et al: The accumulation of whole body skeletal mass in third- and fourth-grade children: Effects of age, gender, ethnicity, and body composition. Bone 20: 73-78, 1997
43. Arabi A, Tamim H, Nabulsi M, et al: Sex differences in the effect of body-composition variables on bone mass in healthy children and adolescents. Am J Clin Nutr 80:1428-1435, 2004
44. Bond GL, Hirshfield KM, Kirchhoff T, et al: MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res 66:5104-5110, 2006
45. Couzin J: Medicine. Estrogen's ties to COX-2 may explain heart disease gender gap. Science 306:1277, 2004
46. Viau V, Bingham B, Davis J, et al: Gender and puberty interact on the stress-induced activation of parvocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 146:137-146, 2005
47. Bilezikian JP, Morishima A, Bell J, et al: Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599-603, 8-27-1998
48. Roche JK, Crum P: Local immunity and the uterine cervix: Implications for cancer-associated viruses. Cancer Immunol Immunother 33:203-209, 1991
49. Fredriksson J, Anevski D, Almgren P, et al: Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality. PLoS ONE 2:e285, 2007
50. McCarthy JJ, Lewitzky S, Reeves C, et al: Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations. Hum Hered 55:163-170, 2003
51. Patsopoulos NA, Tatsioni A, Ioannidis JP: Claims of sex differences: An empirical assessment in genetic associations. JAMA 298:880-893, 2007
52. Havill LM, Mahaney MC, Binkley L, et al: Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res 22:737-746, 2007
53. Leonard MB, Shults J, Wilson BA, et al: Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutr 80:514-523, 2004
54. Schmid HH, Bandi PC, Madson TH, et al: Substrate specificity in plasmalogen biosynthesis: Desaturation of 1-O-hexadecyloxyethyl-2-acylglycero-3- phosphoethanolamine in developing rat brain. Biochim Biophys Acta 488:172-178, 1977
55. Pocock NA, Eisman JA, Hopper JL, et al: Genetic determinants of bone mass in adults: A twin study. J Clin Invest 80:706-710, 1987